Contract HHSO100201700026C
Novartis Pharmaceuticals Corporation · Department Of Health And Human Services · September 30, 2020
Novartis Pharmaceuticals Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 30, 2020 for $2.91 million of work in research and development in biotechnology. Performance is in East Hanover, NJ. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $54.99 million.
Contract details
- PIID
- HHSO100201700026C
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- R&D- Medical: Other (Applied Research/Exploratory Development)
- Place of performance
- East Hanover, NJ
- First action
- September 30, 2020
Description
TO DEVELOP ELTROMBOPAG VIA THE ANIMAL RULE FOR THE TREATMENT OF HEMATOPOIETIC SUB-SYNDROME OF ACUTE RADIATION SYNDROME (H-ARS) DURING THE FIELD CARE PHASE OF TREATMENT TO FULFILL AND UNMET NEED IN THE CURRENT FEDERAL MEDICAL COUNTERMEASURE (MCM) PORT
Modification timeline
-
September 30, 2020Mod P00006 · Funding Only Action$30.32M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201700026C?
Contract HHSO100201700026C is a federal contract awarded to Novartis Pharmaceuticals Corporation by Department Of Health And Human Services on September 30, 2020 for $2.91 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSO100201700026C?
Novartis Pharmaceuticals Corporation won contract HHSO100201700026C from Department Of Health And Human Services.
How much is contract HHSO100201700026C worth?
Contract HHSO100201700026C has obligated $2.91 million to date, with a total potential value of $54.99 million if all options are exercised.